Name of the institution
Stichting SafeCare, a not-for-profit foundation established in Amsterdam, hereinafter referred to as SafeCare.
RSIN/fiscal number
SafeCare’s RSIN number is 855822661. The Chamber of Commerce number is 64758796.
Contact details
SafeCare Foundation
AHTC, Tower 4C, Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands
P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
Tel. +31 (0)20 2103920 / info@safe-care.org
Objectives
The foundation aims to: promote the quality, safety, and accessibility of healthcare, particularly in low- and middle-income countries, and furthermore, anything directly or indirectly related to this or that may be conducive thereto, all in the broadest sense of the word.
The SafeCare Foundation falls under the umbrella of the PharmAccess Foundation (www.pharmaccess.org), with the Board of Directors consisting of the same members. The annual accounts are available to the PharmAccess Foundation.
The foundation devotes its resources exclusively to the realization of its objective.
The resources are used for, among other things:
- development and maintenance of quality standards, tools, and systems;
- conducting assessments and quality improvement processes;
- training and capacity building of healthcare providers and institutions;
- technical assistance and guidance;
- monitoring, evaluation, and research;
- collaboration with partners and implementation of programs;
- reasonable and necessary costs for management and administration.
Policy plan
A concise version of our policy plan (in Dutch) can be downloaded here.
Governance
The Nicole Spieker is the managing director of Stichting SafeCare. The composition of the Board is as follows: N. Spieker (statutory board), A. Poels (interim statutory board), K.O. Rogo (supervisory board), E. Boerhof (supervisory board), E. Bronkhorst (supervisory board), and M. Schneider (supervisory board). The Supervisory Board of the PharmAccess Foundation is also the Supervisory Board of SafeCare.
The Board meets periodically and makes decisions in accordance with the Articles of Association and the Internal Regulations (if applicable).
Remuneration policy
The “DG-norm” (also called “MFS II norm”) was introduced by the Dutch Ministry of Foreign Affairs at the end of 2009. According to this salary standard, the directors of organizations involved in development cooperation do not earn more than the basic salary earned by a Director-General (DG) at a Dutch Ministry. SafeCare adheres to this norm, and is also compliant with the “VFI-norm” and the “Wet Normering Topinkomens”, formerly known as the “Balkenende-norm.” Supervisory Board members are unpaid. They receive no remuneration or expense allowance. They do have the right to request compensation for costs incurred, such as travel expenses or telephone costs.
Report on recent activities
Please consult the PharmAccess Progress Report 2024 the PharmAccess Annual Accounts 2024 .
Financial accountability
SafeCare’s financial resources may consist of subsidies, donations, bequests, assets acquired by testamentary disposition and any further revenues.